➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Express Scripts
McKinsey
McKesson
Moodys

Last Updated: May 25, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 209866


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 209866 describes PINDOLOL, which is a drug marketed by Acp Nimble, Ani Pharms Inc, Bayshore Pharms Llc, Mylan Pharms Inc, Nostrum Labs, Nostrum Labs Inc, Purepac Pharm, Sun Pharm Industries, Watson Labs, and Zydus Pharms, and is included in fourteen NDAs. It is available from six suppliers. Additional details are available on the PINDOLOL profile page.

The generic ingredient in PINDOLOL is pindolol. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the pindolol profile page.
Summary for 209866
Tradename:PINDOLOL
Applicant:Zydus Pharms
Ingredient:pindolol
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 209866
Mechanism of ActionAdrenergic beta-Antagonists
Suppliers and Packaging for NDA: 209866
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PINDOLOL pindolol TABLET;ORAL 209866 ANDA Zydus Pharmaceuticals (USA) Inc. 70710-1063 70710-1063-1 100 TABLET in 1 BOTTLE (70710-1063-1)
PINDOLOL pindolol TABLET;ORAL 209866 ANDA Zydus Pharmaceuticals (USA) Inc. 70710-1064 70710-1064-1 100 TABLET in 1 BOTTLE (70710-1064-1)

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength5MG
Approval Date:Aug 18, 2017TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG
Approval Date:Aug 18, 2017TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
McKesson
AstraZeneca
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.